Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$14.26 Mil
% of Total Estimate Gain
114.01%

Endurant Capital Management LP's Aclaris Therapeutics Inc Holding Summary

As of 2024-03-31, Endurant Capital Management LP held - shares of Aclaris Therapeutics Inc(ACRS), totaling N/A. This investment constitutes 0% of their stock portfolio, and Endurant Capital Management LP now holds 0% of the outstanding Aclaris Therapeutics Inc(ACRS) stock.

The initial trade took place in 2019Q1. And since then Endurant Capital Management LP has made 7 purchases of ACRS, at an average price of $4.39, for a total of 2.85 Mil shares. In addition, there have been 9 sales at an average price of $9.39 for 2.85 Mil shares. Based on historical transaction data and ACRS's current price of $1.47, Endurant Capital Management LP's estimated gain on his ACRS holdings is $14.26 Mil, reflecting a 114.01% gain to date.

Endurant Capital Management LP ACRS ($1.47) Holding Chart

Endurant Capital Management LP ACRS ($1.47) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1